Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 27.09.2021 3 Am J Clin Oncol 1 Am J Surg 1 Ann Surg 1 Ann Surg Oncol 5 Br J Surg 3 Cancer 2 Cancer Lett 2 Cancer Res 2 Eur J Cancer 1 Eur J Surg Oncol 2 Gastroenterology 3 Int J Colorectal Dis 4 J Clin Oncol 1 J Natl Cancer Inst 3 J Surg Oncol 1 Nat Rev Cancer 2 Oncol Rep 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. BENSON KRK, Sandhu N, Zhang C, Ko R, et al
   Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
   Am J Clin Oncol. 2021 Sep 17. pii: 00000421-900000000-98532.
   PubMed         Abstract available
   
   
2. MENON A, Abraham AG, Mahfouz M, Thachuthara JJ, et al
   Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
   Am J Clin Oncol. 2021;44:487-494.
   PubMed         Abstract available
   
   
3. LUTSYK M, Awawda M, Gourevich K, Ben Yosef R, et al
   Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
   Am J Clin Oncol. 2021;44:482-486.
   PubMed         Abstract available
   
   

   
   Am J Surg

4. PIKOULI A, Papaconstantinou D, Wang J, Kavezou F, et al
   Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases.
   Am J Surg. 2021 Sep 8. pii: S0002-9610(21)00529.
   PubMed         Abstract available
   
   

   
   Ann Surg

5. BOSTROM P, Hultberg DK, Haggstrom J, Haapamaki MM, et al
   Oncological Impact of High Vascular Tie After Surgery for Rectal Cancer: A Nationwide Cohort Study.
   Ann Surg. 2021;274:e236-e244.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

6. FLOOD M, Ramsay R, Heriot A
   ASO Author Reflections: Organoid-Based Precision Medicine in Colorectal Cancer-Are We There Yet?
   Ann Surg Oncol. 2021 Sep 20. pii: 10.1245/s10434-021-10831.
   PubMed        
   
   

   
   Br J Surg

7. STEPHENSEN BD, Reid F, Shaikh S, Carroll RNR, et al
   Comment on: C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT Study by Plate et al.
   Br J Surg. 2021;108:e232.
   PubMed        
   
   
8. TSENG CH, Chen CC, Tseng CM, Tsai YN, et al
   Comment on: C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT study.
   Br J Surg. 2021;108:e209.
   PubMed        
   
   
9. PLATE JDJ, van de Leur RR, Cats M, Boerma D, et al
   Comment on: C-reactive protein trajectory to predict colorectal anastomotic leak.
   Br J Surg. 2021;108:e231.
   PubMed        
   
   
10. STEPHENSEN BD, Reid F, Shaikh S, Carroll R, et al
    Comment on: C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT Study by Tseng et al.
    Br J Surg. 2021;108:e210.
    PubMed        
    
    
11. CUIJPERS ACM, Heldens AFJM, Bours MJL, van Meeteren NLU, et al
    Relation between preoperative aerobic fitness estimated by steep ramp test performance and postoperative morbidity in colorectal cancer surgery: prospective observational study.
    Br J Surg. 2021 Sep 18. pii: 6372180. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

12. THOMPSON CA, Begi T, Parada H Jr
    Alarming recent rises in early-onset colorectal cancer.
    Cancer. 2021 Sep 16. doi: 10.1002/cncr.33919.
    PubMed        
    
    
13. SHAH RR, Millien VO, da Costa WL Jr, Oluyomi AO, et al
    Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017.
    Cancer. 2021 Sep 16. doi: 10.1002/cncr.33916.
    PubMed         Abstract available
    
    
14. NABI J, Tully KH, Cole AP, Marchese M, et al
    Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Cancer. 2021;127:577-585.
    PubMed         Abstract available
    
    

    
    Cancer Lett

15. YANG F, Duan M, Zheng F, Yu L, et al
    Fas signaling in adipocytes promotes low-grade inflammation and lung metastasis of colorectal cancer through interaction with Bmx.
    Cancer Lett. 2021;522:93-104.
    PubMed         Abstract available
    
    
16. HANADA K, Kawada K, Nishikawa G, Toda K, et al
    Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer.
    Cancer Lett. 2021;522:129-141.
    PubMed         Abstract available
    
    

    
    Cancer Res

17. STOPFER LE, Flower CT, Gajadhar AS, Patel B, et al
    High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors.
    Cancer Res. 2021;81:2495-2509.
    PubMed         Abstract available
    
    
18. GULLULU O, Hehlgans S, Mayer BE, Gossner I, et al
    A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage Response.
    Cancer Res. 2021;81:2304-2317.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

19. KOSMALA R, Fokas E, Flentje M, Sauer R, et al
    Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
    Eur J Cancer. 2021;144:281-290.
    PubMed         Abstract available
    
    
20. SINICROPE FA, Chakrabarti S, Laurent-Puig P, Huebner L, et al
    Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials.
    Eur J Cancer. 2021;144:101-112.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

21. PEI JP, Zhao ZM, Sun Z, Gu WJ, et al
    Development and validation of a novel classification scheme for combining pathological T stage and log odds of positive lymph nodes for colon cancer.
    Eur J Surg Oncol. 2021 Sep 9. pii: S0748-7983(21)00728.
    PubMed         Abstract available
    
    

    
    Gastroenterology

22. LEE JK, Merchant SA, Jensen CD, Murphy CC, et al
    Rising Early-Onset Colorectal Cancer Incidence is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System.
    Gastroenterology. 2021 Sep 20. pii: S0016-5085(21)03534.
    PubMed        
    
    
23. WADA Y, Zhu Z, Goel A
    Re: Noninvasive identification of lymph node metastasis in T1 colorectal cancer by transcriptomic panel based on liquid biopsy assay: additional analytical strategies are needed (GASTRO-D-21-01671).
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03492.
    PubMed        
    
    

    
    Int J Colorectal Dis

24. SMIT MA, van Pelt GW, Terpstra V, Putter H, et al
    Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
    Int J Colorectal Dis. 2021 Sep 17. pii: 10.1007/s00384-021-04023.
    PubMed         Abstract available
    
    
25. HORSEY ML, Sparks AD, Lai D, Herur-Raman A, et al
    Surgical management of splenic flexure colon cancer: a retrospective propensity-matched study comparing open and minimally invasive approaches using the national cancer database.
    Int J Colorectal Dis. 2021 Sep 18. pii: 10.1007/s00384-021-04029.
    PubMed         Abstract available
    
    
26. WARPS AK, Dekker JWT, Tanis PJ, Tollenaar RAEM, et al
    An evaluation of short-term outcomes after reoperations for anastomotic leakage in colon cancer patients.
    Int J Colorectal Dis. 2021 Sep 24. pii: 10.1007/s00384-021-03996.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

27. BOOTH CM, Berry SR
    Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?
    J Clin Oncol. 2021 Sep 24:JCO2101972. doi: 10.1200/JCO.21.01972.
    PubMed        
    
    
28. LENTZ RW, Messersmith WA
    Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.
    J Clin Oncol. 2021 Sep 20:JCO2101993. doi: 10.1200/JCO.21.01993.
    PubMed        
    
    
29. SELIGMANN JF, Fisher DJ, Brown LC, Adams RA, et al
    Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.
    J Clin Oncol. 2021 Sep 18:JCO2101435. doi: 10.1200/JCO.21.01435.
    PubMed         Abstract available
    
    
30. MODEST DP, Karthaus M, Fruehauf S, Graeven U, et al
    Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
    J Clin Oncol. 2021 Sep 17:JCO2101332. doi: 10.1200/JCO.21.01332.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

31. FORMICA V, Sera F, Cremolini C, Riondino S, et al
    KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2021 Sep 20. pii: 6372696. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

32. LAU LW, Kethman WC, Bingmer KE, Ofshteyn A, et al
    Evaluating disparities in delivery of neoadjuvant guideline-based chemoradiation for rectal cancer: A multicenter, propensity score-weighted cohort study.
    J Surg Oncol. 2021;124:810-817.
    PubMed         Abstract available
    
    
33. TURGEON MK, Gamboa AC, Keilson JM, Maniko J, et al
    Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium.
    J Surg Oncol. 2021;124:818-828.
    PubMed         Abstract available
    
    
34. INOUE H, Kawaguchi T, Ikoma H, Morimura R, et al
    Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy.
    J Surg Oncol. 2021;124:791-800.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

35. KERK SA, Papagiannakopoulos T, Shah YM, Lyssiotis CA, et al
    Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment.
    Nat Rev Cancer. 2021;21:510-525.
    PubMed         Abstract available
    
    

    
    Oncol Rep

36. DENG YY, Min YJ, Zhou K, Yang QS, et al
    Identification of the tumorsuppressive role of circular RNAFOXO3 in colorectal cancer via regulation of miR543/LATS1 axis.
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    
37. JIANG F, Ren S, Chen Y, Zhang A, et al
    Fangchinoline exerts antitumour activity by suppressing the EGFRPI3K/AKT signalling pathway in colon adenocarcinoma.
    Oncol Rep. 2021;45:139-150.
    PubMed         Abstract available
    
    

    
    PLoS One

38. ISHIKAWA M, Takashima A, Nagata Y, Sawada R, et al
    Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
    PLoS One. 2021;16:e0257551.
    PubMed         Abstract available
    
    
39. CONTURSI A, Arconzo M, Cariello M, Piglionica M, et al
    let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects.
    PLoS One. 2021;16:e0249238.
    PubMed         Abstract available
    
    
40. OGAWA M, Urano M, Takaishi T, Kan H, et al
    T-staging of rectal cancer: Utility of single-shot turbo spin-echo diffusion-weighted imaging with T2-weighted images and fusion images.
    PLoS One. 2021;16:e0249433.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: